- Home
- CRNX vs SFBS Comparison
CRNX vs SFBS Comparison
Compare CRNX & SFBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | SFBS |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.9B |
| IPO Year | 2018 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CRNX | SFBS |
|---|---|---|
| Price | $47.18 | $72.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $71.00 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.4M | 209.1K |
| Earning Date | 11-06-2025 | 10-20-2025 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | N/A | ★ 24.86 |
| EPS | N/A | ★ 4.67 |
| Revenue | $1,535,000.00 | ★ $497,701,000.00 |
| Revenue This Year | $425.31 | $24.89 |
| Revenue Next Year | $943.50 | $16.87 |
| P/E Ratio | ★ N/A | $15.47 |
| Revenue Growth | ★ 47.74 | 16.24 |
| 52 Week Low | $24.10 | $66.48 |
| 52 Week High | $60.34 | $97.18 |
Technical Indicators
Market Signals| Indicator | CRNX | SFBS |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 52.52 |
| Support Level | $44.52 | $70.63 |
| Resistance Level | $48.62 | $72.49 |
| Average True Range (ATR) | 2.00 | 2.02 |
| MACD | 0.29 | 0.51 |
| Stochastic Oscillator | 72.38 | 88.54 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.